Ipilimumab vs Liraglutide

## Ipilimumab vs Liraglutide: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Liraglutide**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Liraglutide**: GLP-1 receptor agonist enhancing insulin secretion.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Liraglutide — 13 hours.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Liraglutide — Protein.